NCT02674191

Brief Summary

Treating hyperdivergent malocclusion accompanied by open bite could be challenging and may be done by several methods as high pull headgear and posterior bite planes or surgically by maxillary impaction in adults. Nowadays it's the skeletal anchorage system (SAS) era as mini-screws and mini-plates ,hence we are aiming for absolute anchorage, and could minimize patient cooperation and the need for surgical treatment.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2016

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 4, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

May 1, 2016

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

February 23, 2018

Status Verified

February 1, 2018

Enrollment Period

2.1 years

First QC Date

January 29, 2016

Last Update Submit

February 21, 2018

Conditions

Keywords

miniplates ,molar intrusion, hyperdivergent

Outcome Measures

Primary Outcomes (1)

  • Lower facial height: the distance between soft tissue subnasale and gnathion (Sn.Gn) the difference will be measured in mm. before and after posterior segment intrusion

    This measurement relates principally to the vertical dimensions of the upper dento-alveolar process and the mandible.

    6 months

Study Arms (2)

Group 1

EXPERIMENTAL

Device: mini-plates supported molar intrusion (Stryker, Leibinger, GmbH\& Co., Freiburg, Germany) for molar intrusion using miniplates to treat hyperdivergent adolescence Procedure/Surgery: Application of ULTRACARE benzocaine 20%, topical anesthesia (Ultradent Products, Inc) Procedure/Surgery: Administration of , Mepivacaine-l local anesthesia Procedure/Surgery: BETADINE povidone-iodine 10% a local disinfectant Drug: (150g Clindamycin/tds) for 1 week Postoperative antibiotic Drug: (Cataflam 25mg), are prescribed post-operatively an analgesic

Device: mini-plates supported molar intrusionProcedure: Application of ULTRACARE benzocaine 20%,Procedure: Administration of , Mepivacaine-lProcedure: BETADINE povidone-iodine 10%Drug: (150g Clindamycin/tds) for 1 weekDrug: (Cataflam 25mg), are prescribed post-operatively

Group 2

NO INTERVENTION

hyperdivergent adolescence with no intervention

Interventions

(Stryker, Leibinger, GmbH\& Co., Freiburg, Germany) for molar intrusion using miniplates to treat hyperdivergent adolescence

Group 1

topical anesthesia (Ultradent Products, Inc)

Group 1

local anesthesia

Group 1

a local disinfectant

Group 1

Postoperative antibiotic

Also known as: Dalacin
Group 1

an analgesic

Also known as: NSAIDs
Group 1

Eligibility Criteria

Age14 Years - 19 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Mild to moderate skeletal Class II
  • Super eruption of maxillary posterior segment
  • Erupted full set of maxillary permanent teeth except 3rd molar
  • Increased lower facial height

You may not qualify if:

  • Previous orthodontic treatment
  • Any hormonal disorders or syndromes
  • Systemic Disease
  • Facial Asymmetry
  • Para-functional habits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • Kuroda S, Sakai Y, Tamamura N, Deguchi T, Takano-Yamamoto T. Treatment of severe anterior open bite with skeletal anchorage in adults: comparison with orthognathic surgery outcomes. Am J Orthod Dentofacial Orthop. 2007 Nov;132(5):599-605. doi: 10.1016/j.ajodo.2005.11.046.

    PMID: 18005833BACKGROUND
  • Ng J, Major PW, Flores-Mir C. True molar intrusion attained during orthodontic treatment: a systematic review. Am J Orthod Dentofacial Orthop. 2006 Dec;130(6):709-14. doi: 10.1016/j.ajodo.2005.05.049.

    PMID: 17169732BACKGROUND
  • Sherwood KH, Burch JG, Thompson WJ. Closing anterior open bites by intruding molars with titanium miniplate anchorage. Am J Orthod Dentofacial Orthop. 2002 Dec;122(6):593-600. doi: 10.1067/mod.2002.128641.

  • Greenlee GM, Huang GJ, Chen SS, Chen J, Koepsell T, Hujoel P. Stability of treatment for anterior open-bite malocclusion: a meta-analysis. Am J Orthod Dentofacial Orthop. 2011 Feb;139(2):154-69. doi: 10.1016/j.ajodo.2010.10.019.

  • Xun C, Zeng X, Wang X. Microscrew anchorage in skeletal anterior open-bite treatment. Angle Orthod. 2007 Jan;77(1):47-56. doi: 10.2319/010906-14R.1.

MeSH Terms

Interventions

WW Domain-Containing OxidoreductaseClindamycinDiclofenacAnti-Inflammatory Agents, Non-Steroidal

Intervention Hierarchy (Ancestors)

Short Chain Dehydrogenase-ReductasesNAD (+) and NADP (+) Dependent Alcohol OxidoreductasesAlcohol OxidoreductasesOxidoreductasesEnzymesEnzymes and CoenzymesTumor Suppressor ProteinsNeoplasm ProteinsProteinsAmino Acids, Peptides, and ProteinsLincomycinLincosamidesPyrrolidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsGlycosidesCarbohydratesPhenylacetatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsAnalgesics, Non-NarcoticAnalgesicsSensory System AgentsPeripheral Nervous System AgentsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesAnti-Inflammatory AgentsTherapeutic UsesAntirheumatic Agents

Study Officials

  • Manal M El Namrawy, MSc.

    assistant lecturer , Beni suef university

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

January 29, 2016

First Posted

February 4, 2016

Study Start

May 1, 2016

Primary Completion

June 1, 2018

Study Completion

July 1, 2018

Last Updated

February 23, 2018

Record last verified: 2018-02